For metabolic labeling, the F. tularensis wild-type strain (wt) or strain expressing Strep-tagged GapA protein (FSC200/gapA_S) were cultivated in CDM containing the heavy labeled amino acids L-arginine hydrochloride [13C6 15N4] and L-lysine hydrochloride [13C6 15N2] (Sigma–Aldrich, Schnelldorf, Germany) in the same concentrations as in the light medium. After three generations, the incorporation levels were checked by mass spectrometry (MS) and the labeled bacteria were stored as frozen stocks at −150°C. For the experiment, the labeled bacterial stock was cultivated in heavy medium overnight at 37°C, 200 rpm. Non-labeled bacteria were grown in the light medium. The overnight cultures were diluted with fresh media to optical density at 600 nm (OD600nm) = 0.1 and cultivated to OD600nm = 0.8 (approximately 3.2 × 109 bacteria/ml, late exponential phase). Bacteria were then harvested by centrifugation and washed with phosphate-buffered saline (PBS, pH 7.4). At this point, the light and heavy bacteria were mixed in a 1:1 cell ratio. Three sets of biological replicates were prepared. Each set consisted of three samples. In two samples, the wt FSC200 was grown in light medium and the FSC200/gapA_S in heavy medium. For the third sample, the SILAC groups were swapped (FSC200/gapA_S was cultivated in light medium, wt FSC200 strain in heavy medium). After supplementation with protease inhibitor cocktail Complete EDTA-free (Roche Diagnostics, Mannheim, Germany) and benzonase (150 U/ml; Sigma–Aldrich), the bacterial cells were disrupted in a French press (Thermo IEC, Needham Heights, MA, United States) by two passages at 16,000 psi. Unbroken cells were removed by centrifugation at 6,000 × g for 40 min at 4°C. The clarified lysate supplemented with an appropriate amount of Avidin (11 U/mg; IBA Lifesciences, Göttingen, Germany) was applied on a column containing Strep-Tactin® affinity resin and the GapA/S protein was purified using the Strep-tag® purification system according to the manufacturer’s instructions (IBA Lifesciences).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.